Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestors
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
LIVN
LivaNova PLC LIVN
$80.62
โ–ผ -0.69% 24H
33.9656.9679.96102.96125.962015-102018-062021-022023-102026-06

About

LivaNova is a global medical technology company that develops innovative devices and therapies for cardiac surgery, cardiopulmonary support, and neuromodulation treatments. The company's primary product portfolio includes vagus nerve stimulation therapy for drug-resistant epilepsy and difficult-to-treat depression, aloโ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited Kingdom
Employees3,300
TickerLIVN

Statistics

Market Cap$4.43B
Revenue (TTM)$1.39B
Net Income-$242.5M
Net Margin-17.5%
EPS$1.96
P/E40.79
P/S3.06
P/B3.62
EV/EBITDA15.98
ROE9.5%
Dividend Yieldโ€”
Price$80.62

Data: Twelve Data ยท Revenue = mcap / P/S

LivaNova PLC (LIVN) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap